https://seekingalpha.com/article/4148547-3-things-biotech-learn-today-february-19-2018

Seeking Alpha som publiserte artikkelen ble grunnlagt i 2004 av tidligere Wall Street analytiker David Jackson.
Selskapet rapporterer at det har distribusjonspartnerskap med MSN Money, CNBC, Yahoo! Finance, MarketWatch, NASDAQ og TheStreet,
Fra februar 2014 hadde firmaet 3 millioner registrerte brukere, og tiltrukket 8 millioner unike lesere i måneden.

På side 2 i arttikkelen:

Looking forward: Being able to more carefully monitor and detect bladder cancer, both in the office setting and in surgery, has significant implications for patients, as these tumors, especially very small tumors, can be extremely difficult to detect. And if you can't see it, you often can't monitor or treat until it has become invasive, at which point the management becomes a lot more difficult. I'm not personally aware of other companies pursuing this approach for bladder cancer, so this approval could be a big boon for the PHCUF.
I expect that PHCUF (PHO) will be able to translate this approval into a significant gain for their bottom line.

Merk siste avsnittet:
Forventer att godkjenningen vil gi en betydelig gevinst for bunnlinjen.

Blir spennende dette.